T A Ruff
Overview
Explore the profile of T A Ruff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
562
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andre F, Booy R, Bock H, Clemens J, Datta S, John T, et al.
Bull World Health Organ
. 2008 Feb;
86(2):140-6.
PMID: 18297169
In low-income countries, infectious diseases still account for a large proportion of deaths, highlighting health inequities largely caused by economic differences. Vaccination can cut health-care costs and reduce these inequities....
2.
Russell F, Carapetis J, Liddle H, Edwards T, Ruff T, Devitt J
J Med Ethics
. 2005 Aug;
31(8):490-4.
PMID: 16076978
Objective: To pilot informed consent materials developed for Aboriginal parents in a vaccine trial, and evaluate their design and the informed consent process. Methods: Cross sectional quantitative and qualitative survey...
3.
Cherry C, Kainer M, Ruff T
Intern Med J
. 2003 May;
33(5-6):242-53.
PMID: 12752895
The real risk posed by biological weapons was demonstrated with the distribution of anthrax spores via the USA postal service in 2001. This review outlines the central roles of physicians...
4.
5.
Wilson N, Ruff T, Rana B, Leydon J, Locarnini S
Vaccine
. 2000 May;
18(26):3059-66.
PMID: 10825610
The aims of this project were: (1) to determine the extent to which infant hepatitis B immunisation is preventing chronic hepatitis B infection in children living in a sample of...
6.
Otto B, Suarnawa I, Stewart T, Nelson C, Ruff T, Widjaya A, et al.
Vaccine
. 1999 Oct;
18(5-6):498-502.
PMID: 10519939
We evaluated the immunogenicity of hepatitis B (HB) vaccine in UniJect, a pre-filled, non-reusable injection device, stored at tropical temperatures for up to one month and used to give the...
7.
Pellegrini M, Ruff T
Aust Fam Physician
. 1999 Aug;
28(7):683-8.
PMID: 10431424
Background: Malaria prevention in travellers is typically the most complex travel health issue faced by practitioners. Approximately 300 to 500 million people in the world are infected with malaria and...
8.
Ruff T
Rev Med Virol
. 1999 Jul;
9(2):121-38.
PMID: 10386339
In just under a quarter of a century, the Expanded Programme on Immunisation has been associated with an increase in infant immunisation coverage from around 5% to 80%, and the...
9.
Oman K, Carnie J, Ruff T
Aust N Z J Public Health
. 1997 Jun;
21(3):293-6.
PMID: 9270156
To determine hepatitis B immunisation rates in infants from ethnic groups with hepatitis B surface antigen chronic carrier prevalence over 5 per cent, a questionnaire was sent to all Maternal...
10.
Ruff T
Med J Aust
. 1996 Jul;
165(1):43-5.
PMID: 8676780
Many HIV-infected people travel abroad, and although most can travel in relative safety there are a range of issues and risks to be considered by their medical advisers.